Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2015-11-23 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2015
Transaction in Own Shares Classification · 99% confidence The document is a 'Selskabsmeddelelse' (Company Announcement) dated November 23, 2015, detailing the completion of Novozymes' share buyback program ('aktietilbagekøbsprogram'). It specifically lists the number of shares transacted and the total value, which falls under the category of the company dealing in its own shares. This directly corresponds to the definition for 'Transaction in Own Shares' (POS). The document is short and is an announcement of a transaction, not a comprehensive financial report.
2015-11-23 English
Transaction in Own Shares 2015
Transaction in Own Shares Classification · 100% confidence The document text is very short (270 characters) and describes a transaction where Novozymes bought back a specific number of shares (6,236,623) under a previously announced share repurchase program. The key phrase is 'Pr. 13. november har Novozymes købt i alt 6.236.623 aktier' (On Nov 13, Novozymes bought a total of 6,236,623 shares). This directly relates to the company buying back its own shares. This matches the definition for 'Transaction in Own Shares' (POS). The final sentence 'Læs hele meddelelsen i pdf format' (Read the full announcement in pdf format) suggests this might be an announcement, but the content itself is the core transaction detail, making POS a stronger fit than RPA or RNS, as it is a specific reportable event.
2015-11-16 Danish
Transaction in Own Shares 2015
Transaction in Own Shares Classification · 99% confidence The document explicitly details transactions made under a 'stock buyback program,' reporting the number of shares purchased, the average price, and the total transaction value over several days (November 9 to November 13, 2015). This activity directly corresponds to the company repurchasing its own shares. According to the definitions, 'Transaction in Own Shares (Code: POS)' covers 'Report of the company buying back or selling its own shares (share repurchase/issuance)'. The document is a specific report on this activity, not a general announcement of a report (RPA) or a miscellaneous filing (RNS).
2015-11-16 English
Transaction in Own Shares 2015
Transaction in Own Shares Classification · 100% confidence The document text is very short (269 characters) and describes a specific transaction: Novozymes buying back its own shares (6,096,623 shares for 1,904.3 million DKK) under a previously announced share repurchase program. This directly relates to the company acquiring its own stock. The final sentence, 'Læs hele meddelelsen i pdf format' (Read the full announcement in pdf format), suggests this might be a brief announcement linking to a full document. However, the core content is explicitly about the company buying back shares, which maps precisely to the 'Transaction in Own Shares' definition (POS). Since the content is specific to share repurchase activity, POS is a better fit than the general RPA or RNS fallback.
2015-11-09 Danish
Transaction in Own Shares 2015
Transaction in Own Shares Classification · 98% confidence The document explicitly details transactions made by Novozymes under its stock buyback program, including the number of shares purchased, average prices, and total transaction values over specific dates (November 2 to November 6, 2015). This content directly relates to the company acquiring its own shares, which matches the definition for 'Transaction in Own Shares'. The filing code for this is POS.
2015-11-09 English
Transaction in Own Shares 2015
Transaction in Own Shares Classification · 100% confidence The document text, written in Danish, explicitly states that Novozymes has bought back a specific number of shares (5,967,623) under a share repurchase program announced previously. The text details the transaction value and the overall scope of the buyback program. This directly relates to the company purchasing its own shares. The classification code corresponding to the report of the company buying back or selling its own shares is 'POS' (Transaction in Own Shares). The document is short and mentions reading the full announcement in PDF format, but the content itself is the core transaction report, making POS more specific than RPA or RNS.
2015-11-02 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.